A surgical dressing company faced non-compliance issues with the National Pharmaceutical Pricing Authority (NPPA) regulations due to an MRP increase exceeding the permissible 10% annual cap. Non-compliance with NPPA’s price control regulations threatened penalties and disrupted market operations.
The case was resolved amicably with NPPA accepting the justification for the price increase. The client avoided penalties and continued operations without disruptions. The compliance strategy implemented ensured adherence to NPPA regulations moving forward, safeguarding the client’s market position.
Connect with us